欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2011, Vol. 16 ›› Issue (9): 1047-1051.

• 药物治疗学 • 上一篇    下一篇

右美托咪啶用于全麻术后苏醒期患者镇静的研究

蔡畅, 郭建荣   

  1. 宁波大学医学院附属李惠利医院麻醉科,宁波 315040,浙江
  • 收稿日期:2011-05-03 修回日期:2011-08-06 出版日期:2011-09-26 发布日期:2011-10-11
  • 通讯作者: 郭建荣,男,博士,教授,主任医师,硕士生导师,研究方向:麻醉生理与药理学研究。Tel: 0574-87018725 E-mail: Jianrguo@126.com
  • 作者简介:蔡畅,女,硕士,讲师,主治医师,研究方向:临床麻醉。Tel: 0574-87018726 E-mail: pre_doctorcaichang@hotmail.com

Study of sedation effect with dexmedetomidine on patients after general anaesthesia

CAI Chang, GUO Jian-rong   

  1. Department of Anesthesiology, Lihuili Hospital, Medical School of Ningbo University, Ningbo 315040, Zhejiang, China
  • Received:2011-05-03 Revised:2011-08-06 Online:2011-09-26 Published:2011-10-11

摘要: 目的: 观察右美托咪啶(Dexmedetomidine,DEX)对全麻术后苏醒期患者的安全性及适宜的镇静剂量。方法: 拟行妇科开腹手术患者60例,ASAⅠ~Ⅱ级,年龄40~55岁,体重50~75 kg,手术时间1~2.5 h 之间。麻醉诱导与维持均按公斤体重给予相同药物,术后转入麻醉恢复室(PACU)。将患者随机分为4组:生理盐水对照组(NS组)、右美托咪啶 0.2 μg/kg 组(D1组)、右美托咪啶 0.4 μg/kg 组(D2组)、右美托咪啶 0.6 μg/kg 组(D3组)。观察并记录给药前(T1)、给药后 5 min(T2)、30 min(T3)、拔管前(T4)、拔管后(T5)、出室时(T6)各组患者血流动力学指标的变化以及躁动评分(RS评分)、Ramsay镇静评分(RSS评分)、意识状态评分(OAAS评分)、脑电双频谱指数(BIS)和全麻身体舒适度评分(BCS评分)情况的变化,同时观察各组心血管不良事件的发生情况。结果: 给药后3组心率、血压较给药前有所下降(P<0.05),在T2、T4、T5、T6时点,D2、D3组血压、心率低于其余两组(P<0.05);NS、D1组RS高于D2组、D3组(P<0.05);D3组OAAS和BIS低于其他各组(P<0.05);D3组发生再入睡和心动过缓的比率较高(P<0.05)。结论: 右美托咪啶 0.4 μg/kg 用于全麻术后苏醒期患者镇静是安全的,可明显提高麻醉苏醒质量。

关键词: 右美托咪啶, 苏醒期, 镇静

Abstract: AIM: To observe the safety and the appropriate amount of sedation of dexmedetomidine on the recovery period after general anesthesia. METHODS: Sixty patients undergoing abdominal gynecological surgery after general anesthesia, aged 40-55 yrs, weight 50-75 kg, the operation time between 1-2.5 h. Patients were induced and maintained according to the same kilogram of body weight, then sent into the recovery room after surgery. They were randomly divided into four groups: Saline control group, D1 group: dexmedetomidine group 0.2 μg/kg, D2 Group: dexmedetomidine group 0.4 μg/kg, D3 Group: dexmedetomidine group 0.6 μg/kg. The blood pressure, heart rate, respiration rate, pulse oxygen saturation and Ramsay sedation scores were monitored before(T1) and after using the drugs 5 min(T2), 30 min(T3), before(T4) and after tracheal extubation(T5), and leaving room(T6). Blood gas was recorded before(T1) and after using the drugs 30 min(T3), and leaving room(T6). Time of extubation and leaving room, then sleep, bradycardia, hypotension and other side effects were observed. RESULTS: Compared with before administration, the blood pressure and heart rate decreased in the three groups after administration(P<0.05). The blood pressure and heart rate in D2 Group and D3 Group were lower than the other groups at T2, T4-T6(P<0.05). RS in NS Group and D1 Group were higher than D2 Group and D3 Group (P<0.05). OAAS and BIS in D3 Group were lower than other groups. Ramsay sedation scores in D3 Group were higher than the other groups (P<0.05). D3 Group had the higher risk back to sleep and bradycardia (P<0.05). CONCLUSION: It is safe that DEX is used in patients with sedation during the recovery period after general anesthesia. It improves the quality of awakening.

Key words: Dexmedetomidine, Recovery period, Sedation

中图分类号: